LaurusLabs climbs 6% on USFDA approval

LaurusLabs climbs 6% on USFDA approval

Thursday, August 30, 2018
Shares of Laurus Labs climbed 6 percent on Thursday after the pharma company received USFDA approval for a generic drug used in the treatment of diabetes.
The stock rose 5.84 percent to hit a high of Rs 464.35 on the BSE.

For more information on Indian Share Market Tips For Tomorrow

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »